Ipsen SA annual current ratio
2020
2021
2022
2023
2024
2025
Ipsen SA Current Ratio Growth & History (IPN)
Ipsen SA's current ratio was 1.96 for fiscal 2025.
View full Ipsen SA company overviewIpsen SA annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.96 | 0.62 | +46.08% |
| 2024 | 2024-12-31 | 1.34 | 0.18 | +15.05% |
| 2023 | 2023-12-31 | 1.17 | −0.63 | −35.00% |
| 2022 | 2022-12-31 | 1.80 | 0.20 | +12.88% |
| 2021 | 2021-12-31 | 1.59 | 0.29 | +22.21% |
| 2020 | 2020-12-31 | 1.30 | — | — |
Ipsen SA quarterly current ratio
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.97 | −0.02 | −0.94% |
| Q4 2025 | 2025-12-31 | 1.96 | 0.62 | +46.08% |
| Q2 2025 | 2025-06-30 | 1.98 | — | — |
| Q4 2024 | 2024-12-31 | 1.34 | — | — |
Ipsen SA current ratio trends
Over the last five fiscal years, Ipsen SA's current ratio increased from 1.30 to 1.96, a change of 0.66. The latest reported quarter, Q2 2026, shows 1.97.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as reported current assets divided by reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...
